Literature DB >> 8981030

Lipid peroxidation and changes in the ubiquinone content and the respiratory chain enzymes of submitochondrial particles.

P Forsmark-Andrée1, C P Lee, G Dallner, L Ernster.   

Abstract

The relationship between, lipid peroxidation induced by ascorbate and adenosine ADP/Fe3+, and its effect on the respiratory chain activities of beef heart submitochondrial particles has been investigated. Lipid peroxidation, measured as thiobarbituric acid reactive substance formation, resulted in an inhibition of the NADH and succinate oxidase activities. Examination of several partial reactions of the respiratory chain revealed inactivation primarily of those involving endogenous ubiquinone, i.e., NADH- and succinate-ubiquinone1 and cytochrome c reductases. Ubiquinol-cytochrome c reductase, measured with reduced ubiquinone2 as electron donor, was unaffected. The amount of NADH- or succinate-reducible cytochrome b in the presence of cyanide was strongly decreased, but could be recovered by the addition of antimycin. There occurred a substantial decrease of the ubiquinone content in the course of lipid peroxidation, with a linear relationship between this decrease and the NADH and succinate oxidase activities. The results are consistent with the conclusion that the ubiquinone pool undergoes an oxidative modification during lipid peroxidation, to a form that can no longer function as a component of the respiratory chain. Lipid peroxidation also led to a partial inhibition of the succinate dehydrogenase and cytochrome c oxidase activities and a minor decrease of the cytochrome c and cytochrome a contents. Reduction of endogenous ubiquinone prevented lipid peroxidation as well as the concomitant modification of ubiquinone and inactivation of the respiratory chain. These observations suggest that the destruction of ubiquinone through lipid peroxidation is the primary cause of inactivation of the respiratory chain, and emphasize the antioxidant role of ubiquinol in preventing these effects. The possible implications of these findings for regulation of the cellular turnover of ubiquinone by the prevailing oxidative stress are discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8981030     DOI: 10.1016/s0891-5849(96)00330-9

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  31 in total

1.  A randomized, double-blind, placebo-controlled study of oral coenzyme Q10 to relieve self-reported treatment-related fatigue in newly diagnosed patients with breast cancer.

Authors:  Glenn J Lesser; Doug Case; Nancy Stark; Susan Williford; Jeff Giguere; L Astrid Garino; Michelle J Naughton; Mara Z Vitolins; Mark O Lively; Edward G Shaw
Journal:  J Support Oncol       Date:  2013-03

2.  Curcumin nanoparticles attenuate neurochemical and neurobehavioral deficits in experimental model of Huntington's disease.

Authors:  Rajat Sandhir; Aarti Yadav; Arpit Mehrotra; Aditya Sunkaria; Amandeep Singh; Sadhna Sharma
Journal:  Neuromolecular Med       Date:  2013-09-06       Impact factor: 3.843

3.  Coenzyme Q10 inhibits glutamate excitotoxicity and oxidative stress-mediated mitochondrial alteration in a mouse model of glaucoma.

Authors:  Dongwook Lee; Myoung Sup Shim; Keun-Young Kim; You Hyun Noh; Heemin Kim; Sang Yeop Kim; Robert N Weinreb; Won-Kyu Ju
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-02-18       Impact factor: 4.799

4.  Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects.

Authors:  R T Matthews; L Yang; S Browne; M Baik; M F Beal
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

5.  Protective effects of dietary avocado oil on impaired electron transport chain function and exacerbated oxidative stress in liver mitochondria from diabetic rats.

Authors:  Omar Ortiz-Avila; Marco Alonso Gallegos-Corona; Luis Alberto Sánchez-Briones; Elizabeth Calderón-Cortés; Rocío Montoya-Pérez; Alain R Rodriguez-Orozco; Jesús Campos-García; Alfredo Saavedra-Molina; Ricardo Mejía-Zepeda; Christian Cortés-Rojo
Journal:  J Bioenerg Biomembr       Date:  2015-06-10       Impact factor: 2.945

Review 6.  The effect of HMG-CoA reductase inhibitors on coenzyme Q10: possible biochemical/clinical implications.

Authors:  Iain P Hargreaves; Andrew J Duncan; Simon J R Heales; John M Land
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

7.  Development and validation of a screening assay for the evaluation of putative neuroprotective agents in the treatment of Parkinson's disease.

Authors:  C J Yong-Kee; D Salomonczyk; J E Nash
Journal:  Neurotox Res       Date:  2010-04-02       Impact factor: 3.911

8.  Impaired mitochondrial functions in organophosphate induced delayed neuropathy in rats.

Authors:  Anwar Masoud; Ravi Kiran; Rajat Sandhir
Journal:  Cell Mol Neurobiol       Date:  2009-12       Impact factor: 5.046

Review 9.  Reactive oxygen and nitrogen species in steatotic hepatocytes: a molecular perspective on the pathophysiology of ischemia-reperfusion injury in the fatty liver.

Authors:  Megan J Reiniers; Rowan F van Golen; Thomas M van Gulik; Michal Heger
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

10.  Targeting the progression of Parkinson's disease.

Authors:  J L George; S Mok; D Moses; S Wilkins; A I Bush; R A Cherny; D I Finkelstein
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.